Alteration of Tumor Spectrum by ISGylation in P53-Deficient Mice

Cancer Biology and Therapy - United States
doi 10.4161/cbt.8.12.8558
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Stochastic Modelling of Tumorigenesis in P53 Deficient Mice

British Journal of Cancer
Cancer ResearchOncology
1998English

Developmental Defects and P53 Hyperacetylation in Sir2 Homolog (SIRT1)-deficient Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

Genomic Instability and Apoptosis Are Frequent in P53 Deficient Young Mice

Oncogene
Cancer ResearchGeneticsMolecular Biology
1997English

Accelerated Tumor Growth in Mice Deficient in DNAM-1 Receptor

Journal of Experimental Medicine
MedicineAllergyImmunology
2008English

Override of the Osteoclast Defect in Osteopontin-Deficient Mice by Metastatic Tumor Growth in the Bone

American Journal of Pathology
Forensic MedicinePathology
2006English

Deficient Arginase II Expression Without Alteration in Arginase I Expression Attenuated Experimental Autoimmune Encephalomyelitis in Mice

Immunology
AllergyImmunology
2018English

Endothelial Dysfunction in Tristetraprolin-Deficient Mice Is Not Caused by Enhanced Tumor Necrosis Factor-Α Expression

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Tumor Suppression by P53: Fall of the Triumvirate?

Cell
BiochemistryGeneticsMolecular Biology
2012English

Small-Molecule Inhibition of Wee1 Kinase by MK-1775 Selectively Sensitizes P53-Deficient Tumor Cells to DNA-damaging Agents

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy